TriOn Pharma was delighted to attend the COPD UK Conference 2026, held on Monday, 1 June and Tuesday, 2 June 2026, at The Spine (Royal College of Physicians Building), Liverpool, UK. The two-day conference provided an excellent opportunity to connect with respiratory specialists, GPs, respiratory nurses, pharmacists and healthcare professionals dedicated to improving respiratory health, advancing clinical knowledge and supporting effective management of Chronic Obstructive Pulmonary Disease (COPD).
At the conference, we proudly showcased our respiratory care portfolio, including the EasyChamber Spacer Device, Easy Peak Flow Meter and PulmoClear. Our participation highlighted TriOn Pharma's commitment to providing practical, reliable and patient-focused respiratory care solutions that support effective inhaler technique, respiratory monitoring and airway clearance.
Our EasyChamber Spacer Device generated valuable discussions around optimising inhaler technique and supporting effective inhaled medication delivery for patients managing respiratory conditions such as COPD and asthma.
The EasyChamber Spacer Device is designed for use with compatible pressurised metered-dose inhalers (pMDIs), helping patients who may experience difficulties coordinating inhaler activation with inhalation.
Throughout the conference, we highlighted the importance of correct inhaler technique, appropriate spacer device selection and patient education in supporting effective respiratory management.
We also showcased our Easy Peak Flow Meter, highlighting its role in measuring peak expiratory flow and supporting regular respiratory monitoring.
The device provides a practical solution for healthcare professionals and patients to monitor changes in airflow, particularly in asthma management, where peak flow measurements can help assess respiratory control and identify variations in lung function.
Discussions focused on the importance of respiratory monitoring, patient awareness and appropriate clinical assessment in supporting informed decisions about respiratory care.
Alongside our respiratory monitoring and inhaler support products, we proudly presented PulmoClear, highlighting its role in supporting airway clearance and respiratory wellbeing.
PulmoClear generated valuable conversations around the challenges of mucus clearance and secretion management in patients with respiratory conditions, including COPD.
We discussed the importance of airway clearance techniques in supporting patients who experience difficulty clearing respiratory secretions and how suitable airway clearance devices can complement respiratory care plans under the guidance of healthcare professionals.
Throughout the two-day conference, our team had the pleasure of engaging with respiratory consultants, specialist nurses, GPs, pharmacists and other healthcare professionals, exchanging valuable insights into the everyday challenges of COPD management and respiratory care.
These conversations provided an excellent opportunity to demonstrate how our EasyChamber Spacer Device, Easy Peak Flow Meter and PulmoClear can support different aspects of respiratory management, from inhaler technique and airflow monitoring to airway clearance.
The event also provided a valuable platform to discuss the importance of patient education, appropriate device selection and ongoing respiratory support in helping individuals manage chronic respiratory conditions.
At TriOn Pharma, we remain committed to working closely with healthcare professionals to provide high-quality, accessible and effective respiratory care solutions.
Through our growing respiratory portfolio, we aim to support healthcare professionals in delivering practical, patient-centred care while promoting effective inhaler use, respiratory monitoring, airway clearance and patient confidence in managing long-term respiratory conditions.
We recognise the vital role respiratory healthcare professionals play in supporting patients living with COPD and other chronic respiratory diseases, and we remain dedicated to providing solutions that complement their clinical expertise and help improve patients' everyday quality of life.
A big thank you to the COPD UK Conference 2026 organisers and everyone who visited and connected with our team during the Liverpool event. We look forward to continuing these valuable conversations, strengthening professional relationships and supporting advancements in respiratory care and COPD management across the UK.
